Experimental Eye Research · 2017 · 39 citations · 66 references
MedicineOphthalmologyPharmacologyInflammationNeuroimmunologyOcular PharmacologyGlaucomaNeuroprotectionNeuroprotective PharmacologyOcular Cytokine BiologyOcular InflammationRetinal PharmacotherapyDocosahexaenoic AcidEicosapentaenoic AcidFatty AcidsNeuroprotective AgentsNeuroprotective MechanismsNeuroprotective ResponsesOmega-3 Fatty AcidsOmega-6 Fatty Acids
). ω3-PUFA supplementation alone or timolol alone, significantly increased protein expression levels of M1 macrophage-secreted inducible nitric oxide synthase and M2 macrophage-secreted arginase-1 in the retina, which led to significant decreases in the expression levels of tumour necrosis factor-α (TNF-α). ω3-PUFA supplementation alone also resulted in significantly reduced expression of interleukin-18 (IL-18). ω3-PUFA + timolol treatment had no effect on the expression level of any of the aforementioned mediators in the retina. Supplementation with ω3-PUFAs has neuroprotective effect in the retinas of DBA/2J mice that is enhanced when combined with timolol eye drops. The continued inflammation following ω3-PUFAs + timolol treatment suggests that downregulation of IL-18 and TNF-α may not be the only factors involved in ω3-PUFA-mediated neuroprotection in the retina.
66
Reduction of Intraocular Pressure and Glaucoma Progression
Anders Heijl · Archives of Ophthalmology · 2002 · 3.3K citations
The Ocular Hypertension Treatment Study
Mae O. Gordon · Archives of Ophthalmology · 2002 · 2.6K citations
Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice.
Simon W. M. John, Richard S. Smith, Olga V. Savinova et al. · PubMed · 1998 · 558 citations · Full text